Production (Stage)
Guardant Health, Inc.
GH
$38.60
$0.5951.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 774.00M | 739.02M | 692.26M | 643.81M | 603.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 774.00M | 739.02M | 692.26M | 643.81M | 603.73M |
| Cost of Revenue | 299.23M | 289.80M | 274.72M | 257.85M | 239.28M |
| Gross Profit | 474.77M | 449.22M | 417.53M | 385.96M | 364.45M |
| SG&A Expenses | 576.88M | 545.06M | 504.68M | 462.90M | 453.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.23B | 1.18B | 1.12B | 1.07B | 1.05B |
| Operating Income | -454.58M | -443.59M | -431.21M | -427.55M | -446.53M |
| Income Before Tax | -415.38M | -435.09M | -512.38M | -490.27M | -460.05M |
| Income Tax Expenses | 1.17M | 1.28M | 27.00K | 487.00K | 850.00K |
| Earnings from Continuing Operations | -416.55 | -436.37 | -512.41 | -490.76 | -460.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -416.55M | -436.37M | -512.41M | -490.76M | -460.90M |
| EBIT | -454.58M | -443.59M | -431.21M | -427.55M | -446.53M |
| EBITDA | -412.67M | -401.21M | -388.41M | -384.31M | -403.29M |
| EPS Basic | -3.38 | -3.56 | -4.24 | -4.09 | -3.92 |
| Normalized Basic EPS | -2.17 | -2.15 | -2.10 | -2.10 | -2.15 |
| EPS Diluted | -3.38 | -3.56 | -4.24 | -4.09 | -3.92 |
| Normalized Diluted EPS | -2.17 | -2.15 | -2.10 | -2.10 | -2.15 |
| Average Basic Shares Outstanding | 493.12M | 490.96M | 485.72M | 480.40M | 466.76M |
| Average Diluted Shares Outstanding | 493.12M | 490.96M | 485.72M | 480.40M | 466.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |